Media

Vivet’s Second Gene Therapy Product, VTX-803 for PFIC3, Receives US and European Orphan Drug Designation

Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference

Doctrin raises SEK 83 million in financing round to fuel further expansion

New analysis confirms that multiple myeloma patients in the OCEAN study stay on treatment longer than previously estimated – results expected H1-2021

Oncopeptides reinitiates patient enrollment to the melflufen clinical program following a temporary pause due to the COVID-19 pandemic

BONESUPPORT has completed a directed share issue raising SEK 378 million

BONESUPPORT intends to carry out a directed share issue

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Interim Report Q1 2020